AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACIU | AZN | AMGN | GILD | VRTX |
| Company | AC Immune S.A. | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.31 | 202.55 | 346.18 | 138.26 | 435.28 |
| High | 3.33 | 204.73 | 351.72 | 141.40 | 444.79 |
| Low | 3.19 | 202.07 | 345.41 | 137.60 | 435.28 |
| Latest | 3.19 | 204.38 | 350.95 | 140.45 | 444.28 |
| Change | -0.11 | +2.14 | +1.13 | +1.42 | +4.23 |
| % Change | -3.33% | +1.06% | +0.32% | +1.02% | +0.96% |
| Volume | 176,800 | 2,257,500 | 2,106,700 | 6,473,700 | 1,445,500 |
| 20-Day Average Volume | 241,430 | 1,901,360 | 2,795,955 | 6,080,245 | 1,341,360 |
| Previous Close | 3.30 | 202.24 | 349.82 | 139.03 | 440.05 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.98 | 195.00 | 350.31 | 139.28 | 446.04 |
| 20-Day Raw Stochastic | 68.09% | 88.28% | 47.12% | 51.17% | 44.04% |
| 20-Day Relative Strength | 54.40 | 58.93 | 47.13 | 49.38 | 46.35 |
| Weighted Alpha | +63.90 | +50.63 | +25.73 | +33.84 | -4.97 |
| Today's Opinion | 56% Buy | 88% Buy | 56% Buy | 56% Buy | 8% Buy |
| Previous Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 8% Sell |
| Last Month's Opinion | 24% Buy | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.57% since 04/07/26 | +1.78% since 04/07/26 | +3.22% since 04/07/26 | +1.19% since 04/07/26 | +2.88% since 04/07/26 |
| Low | 3.11 on 04/08/26 | 200.70 on 04/13/26 | 342.35 on 04/08/26 | 137.02 on 04/13/26 | 432.33 on 04/08/26 |
| High | 3.49 on 04/09/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 447.00 on 04/09/26 |
| 1-Month | |||||
| %Chg | +5.80% since 03/13/26 | +7.63% since 03/13/26 | -4.17% since 03/13/26 | -3.13% since 03/13/26 | -5.34% since 03/13/26 |
| Low | 2.55 on 03/30/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 425.26 on 04/07/26 |
| High | 3.49 on 04/09/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 476.17 on 03/16/26 |
| 3-Month | |||||
| %Chg | -13.08% since 01/14/26 | +6.07% since 01/14/26 | +6.68% since 01/14/26 | +13.20% since 01/14/26 | -1.17% since 01/14/26 |
| Low | 2.44 on 02/24/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 425.26 on 04/07/26 |
| High | 3.90 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +3.91% since 10/14/25 | +20.05% since 10/14/25 | +19.43% since 10/14/25 | +18.54% since 10/14/25 | +7.78% since 10/14/25 |
| Low | 2.44 on 02/24/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 4.00 on 10/29/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 324,659 | 316,974,592 | 189,402,464 | 174,329,632 | 113,007,056 |
| Shares Outstanding, K | 101,774 | 1,550,908 | 539,685 | 1,241,222 | 254,360 |
| Annual Sales | 4,310,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -85,030,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 450,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -18,360,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.63 | 0.35 | 0.47 | 0.39 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 03/13/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 04/29/26 | 04/29/26 | 04/30/26 | 05/07/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.08 | 16.01 | 17.06 | 26.80 |